Safer-Med

Real-time Medication Safety Net at the Dispensing Cabinet

Medication errors are systemic failures — and at the moment a nurse pulls a dose from the cabinet, no check re-links that dose to the patient as they are now. Safer-Med is that check. Personalized clinical rules re-assess every dispense and override against that patient’s full clinical profile — catching an approved order that has turned unsafe since it was written. On overrides, a targeted AI check adds a second look for a likely wrong-drug or wrong-patient pull. Both reach the nurse holding the dose, in time to review — Safer-Med never blocks the cabinet.

Start a conversation See how it works

Illustrative — safe when written · unsafe two days later · surfaced at the cabinet, in time to review

  • Enoxaparin 80 mg

    Platelets fall to 22 K/µL

    Full anticoagulant dose on a crashing count — major bleed risk.

    Held
  • Metformin

    Creatinine climbs, eGFR 24

    Continuing in acute kidney injury risks lactic acidosis.

    Held
  • Potassium chloride 40 mEq

    Serum K⁺ already 5.9

    Another dose pushes toward a fatal arrhythmia.

    Held
  • Ketorolac

    eGFR drops below 30

    NSAID on new renal impairment — AKI and bleeding.

    Held
  • Vancomycin

    Trough 28, creatinine doubling

    Nephrotoxic dose stacking on failing kidneys.

    Held
  • Insulin sliding scale

    Glucose already 54 mg/dL

    A stacked dose drives severe hypoglycemia.

    Held
  • Digoxin

    Potassium falls to 2.9

    Hypokalemia sharply raises the risk of digoxin toxicity.

    Held

Two leaders, one safety net

It takes two champions — pharmacy and nursing.

Pharmacy owns the cabinet, override governance, and the clinical logic. Nursing owns the moment the dose reaches the patient. Safer-Med is built for both — start where you lead.

For pharmacy leadership

Close the gap your stack leaves at the cabinet

A real-time re-check at every dispense and override — tuned to override governance and Joint Commission anticoagulant safety, with pharmacist time focused on the few overrides that warrant it.

  • Dispense & override re-checked in real time
  • AI-triaged override review
  • Read-only to the EMR · fully reversible
Go to the pharmacy view For nursing leadership

A backstop that has your nurses’ backs

A quiet, advisory heads-up to the nurse holding the dose — support, not surveillance. On the phone they already carry, with no new app and no routine additional charting.

  • Advisory by design — the nurse decides
  • No new app, login, or routine charting
  • Alert burden measured in shadow mode first
Go to the nursing view

The gap

Three systemic gaps let an unsafe dose reach the patient.

The automated dispensing cabinet is the last point a medication passes before it reaches the patient. The order was checked when it was written and again at pharmacy review — but it is not re-checked at the cabinet, where the clinical picture may have changed. Three well-documented gaps get past that point, and no single system in today’s stack closes them in real time.

Overrides

Unsafe doses leave the cabinet on override

On override, a nurse pulls a medication before any pharmacist reviews the order — and a wrong-drug pull can be fatal. A paralytic withdrawn in place of the sedative it sits beside, under time pressure, can kill a patient — and such substitutions have. It is a systems failure, not a nursing failure: the medication travels from cabinet to bedside with nothing re-checking it. ISMP recommends limiting overrides to situations where waiting for pharmacist review could adversely affect the patient, and reviewing their appropriateness — but overrides remain common in practice.

Timing

Lab-conditioned safeguards don’t re-fire

The order was reviewed when it was written. If a platelet count, a creatinine, or a vital sign changes the picture two days later, in most workflows nothing re-runs that check at the moment the nurse pulls the dose. Does yours?

Routing

The alert reaches the wrong person

Pharmacy gets a queue. The nurse about to administer gets nothing — and there is usually no closed-loop acknowledgment to tell a pharmacist the dose was held.

The last checkpoint

The last checkpoint, with no real-time backstop.

The clinical checks in the chain fire before the dose is pulled for the patient — at order entry and pharmacy review. The nurse is the last person to touch the dose — and today has no real-time backstop. Safer-Med adds that check: it re-runs at the cabinet, after approval, and reaches the nurse holding the dose in time to review.

Order entry

The EMR checks the order for interactions, dose limits, allergies, and more as the prescriber enters it — against the patient’s profile, as it is at that moment.

Pharmacy review

A pharmacist re-runs those same checks and verifies the order against the patient’s labs, vitals, and history on record at the time of approval.

Dispense at the cabinet — the unguarded gap

Hours or days later the nurse pulls the dose. The patient’s labs, vitals or weight may have changed, the order typically isn’t re-checked against the patient as they are now, and an override skips pharmacy review entirely. This is where Safer-Med re-checks against what changed since approval and surfaces it to the nurse in time to review.

Administration

Barcode scanning confirms the right drug and the right patient — but not whether a new lab or vital has made the dose unsafe.

Clinical surveillance and EMR advisories add real-time checks too — but they reach pharmacists and prescribers, not the nurse at the cabinet. The moment of dispense is the last checkpoint before the dose reaches the patient.

Why it’s worth solving

5.3%

Unrecognized override errors among 664 analyzed overrides at one profiled-ADC hospital — even with overrides held to a 1.9% rate. Low volume isn’t proof of safety (single site, 2024). See the evidence.

26.4%

Of reported medication-override errors involved a high-alert medication — the drugs where a slip does the most harm (PA Patient Safety Authority, 2013–14). See the evidence.

~1 in 4

Hospital admissions carry an adverse event; adverse drug events are the largest category, and over a quarter are preventable (NEJM, 2023). See the evidence.

See the evidence page for the studies behind Safer-Med, each with its setting, sample size and limits.

What we do

Four things your stack may not do at the cabinet today.

Medication errors are systemic failures — so Safer-Med is a systematic safeguard, not just another alert. It sits quietly between the EMR, the cabinets, and the clinical-communications platform your staff already carry, pairing personalized clinical rules — tuned to each patient’s labs, vitals, diagnoses, weight and age — with a targeted AI check on overrides, and routing what matters to the nurse holding the dose.

01 · Personalized rules

Patient-specific clinical rules re-check every dispense and override

Explainable rules weigh each active order against that patient’s own labs, vitals, diagnoses, weight and age — not one-size-fits-all thresholds — so an alert is ready to fire at the next dispense or override event, not at the next pharmacist round.

02 · At the cabinet

Re-checks every dose at the moment of dispense — and flags the one that turned unsafe

Each withdrawal and override is checked against the patient’s live context — active orders, recent labs and vitals, allergies, ward, and admission — right when the dose is pulled.

03 · To the right person

Routes the alert to the nurse holding the dose

The alert reaches the dispensing nurse on the communications app they already use — not a pharmacy queue — and a signed acknowledgment closes the loop back to pharmacy, with escalation when a high-risk alert goes unanswered.

04 · AI review

AI flags a likely wrong-drug or wrong-patient override

On overrides only, a targeted AI model weighs the medication actually pulled against the patient — diagnoses, age, allergies, active therapy, labs — to reach one narrow conclusion: a likely wrong-drug or wrong-patient pull, like a paralytic drawn instead of a sedative. It asks the nurse to verify the medication and patient; it never judges clinical appropriateness or recommends treatment. Pharmacists then review the few overrides that truly warrant a second look, not the whole log.

Who we are

A medication-safety company built around one unguarded moment.

Safer-Med is a clinician-founded medication-safety company. We build one thing, and build it well: a real-time safety net at the dispensing cabinet — the last point a medication passes before it reaches the patient, and the one place today’s stack stops re-checking.

Our premise is that medication harm is a systems problem, not a people problem. Modern EMRs, barcoding, and smart pumps have made care safer — yet an approved order can turn unsafe as the patient changes, and an override can release a drug that doesn’t fit the patient, with no check at the moment of dispense. That gap is what we close — and our measure of success is deliberately narrow: preventable harm caught before it reaches the patient, not alerts sent.

Development partners

Become Safer-Med’s clinical development partner.

Built to deploy. Designed to prove its incremental value in real care. We’re seeking one or two U.S. health-system development partners to validate Safer-Med on your own data and in your own workflows. Each phase is jointly evaluated before the next begins — and no nurse receives a notification until the relevance and the alert burden are acceptable to you.

It takes two champions: pharmacy owns the cabinet, the override governance, and the clinical logic; nursing owns the moment the dose reaches the patient. Both shape what Safer-Med surfaces, when it fires, and how it reaches the floor, with clinical informatics helping design the integration, routing and technical acceptance criteria — see the view for pharmacy leadership, nursing leadership, or clinical informatics.

Phase 1 · Retrospective

What your workflows missed

We run on roughly 12 months of your historical clinical and ADC data and show your medication-safety committee which clinically meaningful risks Safer-Med would have surfaced — measured as findings not already identified or acted on by your existing safeguards, using comparator data and clinician adjudication. Targeted override triage prioritizes review; it never replaces required override governance.

Gate you agree on: does the signal justify a prospective evaluation?

Phase 2 · Shadow mode

Measured before anyone is paged

Safer-Med runs on live feeds with no nurse paged, measuring adjudicated relevance, alerts per 1,000 dispenses and per nurse per shift, processing latency, and routing readiness.

Gate you agree on: are performance and the expected workflow burden acceptable?

Phase 3 · Graded go-live

Reversible, unit by unit

Activate one unit at a time — reversible at any point — under joint pharmacy, nursing and informatics governance, evaluating actual nurse response, escalation, and clinical utility.

Gate you agree on: should deployment expand?

You shape the thresholds, wording, workflow and evaluation criteria, co-generate the evidence, and hold named reference rights (with veto) and preferential founding-partner terms. Every stage is reversible and proceeds only by mutual agreement.

Explore a founding clinical partnership

We start with a short conversation to establish clinical value and fit — then, if it makes sense, a joint pharmacy & nursing workshop to plan an evaluation. No commitment to later phases is required to begin.

Start a conversation.